Scott J Hebbring

Title: The Innovative Work of Scott J Hebbring in Genomic Medicine

Introduction

Scott J Hebbring is an accomplished inventor located in Rochester, MN. He is recognized for his significant contributions to the field of genomic medicine, particularly through his innovative work related to the SULT1A1 gene. With one patent to his name, he has made strides that could impact patient treatment and drug dosages based on genetic factors.

Latest Patents

Scott J Hebbring holds a patent titled "Alterations in the copy number of the SULT1A1 gene." This groundbreaking patent describes methods for determining a patient's sulfonator status as well as establishing dosages of drugs tailored to the copy number of the SULT1A1 gene. This innovation highlights the critical relationship between genetics and personalized medicine.

Career Highlights

Hebbring currently works at the Mayo Foundation for Medical Education and Research, a prestigious institution known for its commitment to advancing healthcare through education, research, and clinical practice. His role there allows him to engage in cutting-edge research while contributing valuable insights to the medical community.

Collaborations

Throughout his career, Scott has collaborated with notable researchers, including Richard M Weinshilboum and Araba A Adjei. These partnerships have helped foster a rich environment for innovation and development in the field of pharmacogenomics, further enhancing the impact of his work.

Conclusion

Scott J Hebbring's inventive approaches to medicine through his research and patent in the SULT1A1 gene demonstrate the vital role of innovation in healthcare. His contributions, along with collaborations with esteemed colleagues, pave the way for enhanced methods of patient care and personalized medicine.